| Name | Title | Type |
|---|---|---|
| Dan Bell | Board Chair | Auditee |
| John Chamberlin | Cpa/Partner | Auditee |
| No contacts on file | ||
| ID | Year | Date Accepted | Auditor | Spend |
|---|---|---|---|---|
| 365093 | 2022 | 2025-08-27 | Chamberlin Owen & CO INC | $3.18M |
| 359062 | 2021 | 2025-06-17 | Chamberlin Owen & CO INC | $5.68M |
| 352320 | 2021 | 2025-04-01 | Chamberlin Owen & CO INC | $5.68M |
| Audit | Year | Accepted | Finding | Ref | Severity | Repeat | Requirement |
|---|---|---|---|---|---|---|---|
| 365093 | 2022 | 2025-08-27 | 1151246 | 2022-004 | Significant Deficiency | Yes | ABFGLN |
| 365093 | 2022 | 2025-08-27 | 1151245 | 2022-003 | Significant Deficiency | Yes | L |
| 365093 | 2022 | 2025-08-27 | 1151244 | 2022-002 | Significant Deficiency | Yes | L |
| 365093 | 2022 | 2025-08-27 | 1151243 | 2022-001 | Material Weakness | Yes | L |
| 365093 | 2022 | 2025-08-27 | 574804 | 2022-004 | Significant Deficiency | Yes | ABFGLN |
| 365093 | 2022 | 2025-08-27 | 574803 | 2022-003 | Significant Deficiency | Yes | L |
| 365093 | 2022 | 2025-08-27 | 574802 | 2022-002 | Significant Deficiency | Yes | L |
| 365093 | 2022 | 2025-08-27 | 574801 | 2022-001 | Material Weakness | Yes | L |
| 359062 | 2021 | 2025-06-17 | 1141573 | 2021-004 | Significant Deficiency | - | ABFGLN |
| 359062 | 2021 | 2025-06-17 | 1141572 | 2021-003 | Significant Deficiency | - | L |
| 359062 | 2021 | 2025-06-17 | 1141571 | 2021-002 | Significant Deficiency | - | L |
| 359062 | 2021 | 2025-06-17 | 1141570 | 2021-001 | Material Weakness | - | L |
| 359062 | 2021 | 2025-06-17 | 565131 | 2021-004 | Significant Deficiency | - | ABFGLN |
| 359062 | 2021 | 2025-06-17 | 565130 | 2021-003 | Significant Deficiency | - | L |
| 359062 | 2021 | 2025-06-17 | 565129 | 2021-002 | Significant Deficiency | - | L |
| 359062 | 2021 | 2025-06-17 | 565128 | 2021-001 | Material Weakness | - | L |
| 352320 | 2021 | 2025-04-01 | 1130168 | 2021-004 | Significant Deficiency | - | ABFGLN |
| 352320 | 2021 | 2025-04-01 | 1130167 | 2021-003 | Significant Deficiency | - | L |
| 352320 | 2021 | 2025-04-01 | 1130166 | 2021-002 | Significant Deficiency | - | L |
| 352320 | 2021 | 2025-04-01 | 1130165 | 2021-001 | Material Weakness | - | L |
| 352320 | 2021 | 2025-04-01 | 553726 | 2021-004 | Significant Deficiency | - | ABFGLN |
| 352320 | 2021 | 2025-04-01 | 553725 | 2021-003 | Significant Deficiency | - | L |
| 352320 | 2021 | 2025-04-01 | 553724 | 2021-002 | Significant Deficiency | - | L |
| 352320 | 2021 | 2025-04-01 | 553723 | 2021-001 | Material Weakness | - | L |